JPWO2022006129A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022006129A5
JPWO2022006129A5 JP2022581404A JP2022581404A JPWO2022006129A5 JP WO2022006129 A5 JPWO2022006129 A5 JP WO2022006129A5 JP 2022581404 A JP2022581404 A JP 2022581404A JP 2022581404 A JP2022581404 A JP 2022581404A JP WO2022006129 A5 JPWO2022006129 A5 JP WO2022006129A5
Authority
JP
Japan
Prior art keywords
composition
weight
methyl
brij
steareth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022581404A
Other languages
English (en)
Japanese (ja)
Other versions
JP7813733B2 (ja
JP2023540664A5 (https=
JP2023540664A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/039646 external-priority patent/WO2022006129A1/en
Publication of JP2023540664A publication Critical patent/JP2023540664A/ja
Publication of JP2023540664A5 publication Critical patent/JP2023540664A5/ja
Publication of JPWO2022006129A5 publication Critical patent/JPWO2022006129A5/ja
Application granted granted Critical
Publication of JP7813733B2 publication Critical patent/JP7813733B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022581404A 2020-06-30 2021-06-29 Ｉｒａｋ４阻害剤及びそれらの局所的使用方法 Active JP7813733B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063046531P 2020-06-30 2020-06-30
US63/046,531 2020-06-30
PCT/US2021/039646 WO2022006129A1 (en) 2020-06-30 2021-06-29 Irak4 inhibitors and topical uses thereof

Publications (4)

Publication Number Publication Date
JP2023540664A JP2023540664A (ja) 2023-09-26
JP2023540664A5 JP2023540664A5 (https=) 2024-06-26
JPWO2022006129A5 true JPWO2022006129A5 (https=) 2024-06-26
JP7813733B2 JP7813733B2 (ja) 2026-02-13

Family

ID=79315566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022581404A Active JP7813733B2 (ja) 2020-06-30 2021-06-29 Ｉｒａｋ４阻害剤及びそれらの局所的使用方法

Country Status (9)

Country Link
US (1) US20230390265A1 (https=)
EP (1) EP4172163A4 (https=)
JP (1) JP7813733B2 (https=)
CN (1) CN116134038A (https=)
AU (1) AU2021300110A1 (https=)
BR (1) BR112022027086A2 (https=)
CA (1) CA3186630A1 (https=)
IL (1) IL298929A (https=)
WO (1) WO2022006129A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230125380A1 (en) * 2019-11-05 2023-04-27 Dermira, Inc. Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by Inflammation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102917751A (zh) * 2010-05-28 2013-02-06 久光制药株式会社 具有带有微小突起的阵列的装置
CN105899505B (zh) 2013-11-08 2018-08-28 武田药品工业株式会社 用于治疗自身免疫病症的吡唑
AR110250A1 (es) * 2016-11-28 2019-03-13 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
JP7108631B2 (ja) * 2017-01-06 2022-07-28 パルヴェラ セラピューティクス、インク． ｍＴＯＲ阻害剤の無水組成物およびその使用方法
WO2019143971A2 (en) * 2018-01-18 2019-07-25 Sienna Biopharmaceuticals, Inc. Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure
RU2020130919A (ru) * 2018-03-29 2022-04-29 Лумоса Терапьютикс Ко., Лтд. Композиции и способы для лечения зуда
AU2019290231A1 (en) * 2018-06-21 2020-12-17 Dermavant Sciences GmbH Topical formulations of DGAT1 inhibitors and their methods of use
WO2020028820A1 (en) * 2018-08-03 2020-02-06 Aldeyra Therapeutics, Inc. Topical compositions and methods of preparation and use
US20230125380A1 (en) * 2019-11-05 2023-04-27 Dermira, Inc. Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by Inflammation

Similar Documents

Publication Publication Date Title
EP2900231B1 (en) Topical ketoprofen composition
US20140182585A1 (en) Aerosol container for foamable compositions
RU2637408C2 (ru) Содержащие ретиноид композиции для местного применения типа эмульсии "масло в воде"
EP1572201B1 (en) Pharmaceutical compositions of sertaconazole for vaginal use
JP7779642B2 (ja) ロキソプロフェン配合皮膚用外用剤
MX2008011435A (es) Composicion farmaceutica para uso externo.
EP1858503B1 (en) Topical gels compositions
AU2016287636B2 (en) Diacerein or rhein topical formulations and uses thereof
JP2011510001A (ja) イミキモド製剤
US20070053984A1 (en) Topical gels compositions
WO2022109626A1 (en) Gel, ointment, and foam formulations of tapinarof and methods of use
EP2874619B1 (fr) Compositions pharmaceutiques topiques de type émulsion h/e contenant un rétinoïde
JP2001518879A (ja) 薬剤化合物の向上した浸透性のための溶媒システム
EP2753179A1 (en) Topical itraconazole formulations and uses thereof
EP2854801B1 (fr) Compositions topiques de type gel aqueux sous forme de suspension homogène d'un principe actif de la classe des rétinoïdes contenant au moins une silice hydrophobe
WO1995028914A1 (en) Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
JPWO2022006129A5 (https=)
WO2020065085A1 (fr) Composition pharmaceutique comprenant de la brimonidine, et ses utilisations
EP3666254B1 (en) Pharmaceutical composition containing (r)-n-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide
WO2014017411A1 (ja) 爪白癬治療用外用剤
RU2457831C1 (ru) Противогрибковый гель для местного нанесения
CN100490899C (zh) 薰草菌素的药用组合物
JPWO2009041714A1 (ja) フリーラジカル性疾患用外用剤
JPH0242812B2 (https=)
WO2026067901A1 (zh) 一种局部药物组合物